SEARCH
Search Details
Ishii Hidenobu
Division of Respirology Neurology and Rheumatology Department of Internal Medicine
Assistant Professor
Research activity information
■ Paper
- Turtle study: A phase II study of durvalumab plus carboplatin and etoposide in elderly patients with extensive-stage small-cell lung cancer (LOGiK 2003)
Hidenobu Ishii; Koichi Azuma; Yuta Yamanaka; Hiroshige Yoshioka; Yukihiro Toi; Naoki Shingu; Katsuhiko Naoki; Masaki Okamoto; Yuko Tsuchiya-Kawano; Taishi Harada; Hiroyuki Inoue; Hiroshi Ishii; Kazuori Tobino; Chiho Nakashima; Yoshifusa Koreeda; Yasushi Hisamatsu; Shinsuke Tsumura; Takashi Inagaki; Keiko Mizuno; Takayuki Shimose; Isamu Okamoto
JTO Clinical and Research Reports, Apr. 2025 - The Impact of Adverse Events in Transbronchial Lung Cryobiopsy on Histopathological Diagnosis.
Kenji Tsumura; Shushi Umemoto; Yoshiaki Zaizen; Goushi Matama; Hidenobu Ishii; Sakiko Sumita; Yousuke Mitsui; Yutaka Ichikawa; Kazuhiro Tabata; Masaki Okamoto; Masaki Tominaga; Jun Akiba; Junya Fukuoka; Tomoaki Hoshino
Journal of clinical medicine, 23 Jan. 2025 - Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529).
Takaaki Tokito; Kazuhiko Yamada; Hidenobu Ishii; Yuichi Takiguchi; Go Saito; Koichi Minato; Hisao Imai; Hiroshi Tanaka; Satoru Miura; Kageaki Watanabe; Yoshifusa Koreeda; Akira Ono; Naoki Furuya; Toshihiro Misumi; Kazushige Hayakawa; Etsuyo Ogo; Hiroaki Okamoto
Radiation oncology (London, England), 04 Jan. 2025 - A phase II study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non-small cell lung cancer (LOGIK1902).
Taishi Harada; Tomonari Sasaki; Hidenobu Ishii; Shinnosuke Takemoto; Yasushi Hisamatsu; Haruhiro Saito; Yasuto Yoneshima; Kazutoshi Komiya; Kosuke Kashiwabara; Katsuhiko Naoki; Tomohiro Ogawa; Hiroaki Takeoka; Koichi Saruwatari; Kensaku Ito; Yuko Tsuchiya-Kawano; Keiko Mizuno; Takayuki Shimose; Yoshiyuki Shioyama; Isamu Okamoto
Thoracic cancer, Oct. 2024 - Thoracic Angiosarcoma Arising from Chronic Tuberculous Pyothorax: A Case Report.
Takayuki Horii; Jun Sasaki; Hidenobu Ishii; Misa Sudou; Reiko Takaki; Takaaki Tokito; Koichi Azuma; Tomoaki Hoshino
Internal medicine (Tokyo, Japan), 04 Sep. 2024 - Reconsidering the Cutoff Value for Sensitive and Refractory Relapses in Extensive-Stage SCLC in the Era of Immunotherapy.
Masahiro Torasawa; Hidehito Horinouchi; Shogo Nomura; Satoshi Igawa; Maiko Asai; Hidenobu Ishii; Hiroshi Wakui; Ryota Ushio; Tetsuhiko Asao; Yukiko Namba; Ryo Koyama; Daisuke Hayakawa; Isana Katayama; Hironari Matsuda; Shinichi Sasaki; Kazuhisa Takahashi; Yukio Hosomi; Katsuhiko Naoki; Yuichiro Ohe
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Feb. 2024 - Obesity may be a risk factor for transbronchial lung cryobiopsy-related adverse events in Japanese patients with interstitial lung disease.
Yoshiaki Zaizen; Shushi Umemoto; Goushi Matama; Yousuke Mitsui; Takayuki Horii; Ryo Yano; Shingo Tsuneyoshi; Jun Sasaki; Hidenobu Ishii; Masaki Okamoto; Masaki Tominaga; Tomoaki Hoshino
Respiratory investigation, Jan. 2024 - Proton Beam Therapy as a Curative Treatment for a Young Case of Unresectable Tracheal Adenoid Cystic Carcinoma.
Takashi Kinoshita; Hidenobu Ishii; Yuki Sakazaki; Koichi Azuma; Jun Sasaki; Takaaki Tokito; Masaki Tominaga; Etsuyo Ogou; Tomotaka Kawayama; Tomoaki Hoshino
Internal medicine (Tokyo, Japan), 01 Oct. 2023 - Utility of non-contrast-enhanced magnetic resonance imaging in predicting preoperative clinical stage and prognosis in patients with thymic epithelial tumor.
Asako Kuhara; Akiko Sumi; Tomonori Chikasue; Atsushi Kawaguchi; Shuichi Tanoue; Shuji Nagata; Masamichi Koganemaru; Toshi Abe; Masaki Kashihara; Masahiro Mitsuoka; Hidenobu Ishii; Koichi Ohshima; Ann N C Leung; Kiminori Fujimoto
Japanese journal of radiology, Mar. 2023 - Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial.
Satoru Miura; Yasuhiro Koh; Koichi Azuma; Hiroshige Yoshioka; Kenichi Koyama; Shunsuke Teraoka; Hidenobu Ishii; Kayoko Kibata; Yuichi Ozawa; Takaaki Tokito; Jun Oyanagi; Toshio Shimokawa; Takayasu Kurata; Nobuyuki Yamamoto; Hiroshi Tanaka
BMC cancer, 03 Jan. 2023 - Phase II study of durvalumab (MEDI 4736) plus carboplatin and etoposide in elderly patients with extensive stage small cell lung cancer: Study protocol of turtle study (LOGIK 2003).
Hidenobu Ishii; Koichi Azuma; Takayuki Shimose; Hiroshige Yoshioka; Takayasu Kurata; Naoki Shingu; Masaki Okamoto; Yosuke Kawashima; Isamu Okamoto
Thoracic cancer, Jan. 2023 - Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developing a prognostic multivariate model.
Koichi Azuma; Huihui Xiang; Tomoyuki Tagami; Rika Kasajima; Yumiko Kato; Sachise Karakawa; Shinya Kikuchi; Akira Imaizumi; Norikazu Matsuo; Hidenobu Ishii; Takaaki Tokito; Akihiko Kawahara; Kenta Murotani; Tetsuro Sasada; Yohei Miyagi; Tomoaki Hoshino
Journal for immunotherapy of cancer, May 2022 - Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases.
Yoshimasa Shiraishi; Takayuki Shimose; Yuko Tsuchiya-Kawano; Hidenobu Ishii; Haruko Daga; Kentaro Ito; Koichi Saruwatari; Isamu Okamoto
Cancer management and research, 2022 - T1 invasive lung adenocarcinoma: Thin-section CT solid score and histological periostin expression predict tumor recurrence.
Ryoji Iwamoto; Shuichi Tanoue; Shuji Nagata; Kazuhiro Tabata; Junya Fukuoka; Masamichi Koganemaru; Akiko Sumi; Tomonori Chikasue; Toshi Abe; Daigo Murakami; Shinzo Takamori; Hidenobu Ishii; Koichi Ohshima; Shoichiro Ohta; Kenji Izuhara; Kiminori Fujimoto
Molecular and clinical oncology, Nov. 2021 - Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy.
Norikazu Matsuo; Koichi Azuma; Takashi Kojima; Hidenobu Ishii; Takaaki Tokito; Kazuhiko Yamada; Tomoaki Hoshino
Investigational new drugs, Aug. 2021 - Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial.
Keunchil Park; Mustafa Özgüroğlu; Johan Vansteenkiste; David Spigel; James C H Yang; Hidenobu Ishii; Marina Garassino; Filippo de Marinis; Aleksandra Szczesna; Andreas Polychronis; Ruchan Uslu; Maciej Krzakowski; Jong-Seok Lee; Luana Calabrò; Osvaldo Arén Frontera; Huiling Xiong; Marcis Bajars; Mary Ruisi; Fabrice Barlesi
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Aug. 2021 - Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy.
Hidenobu Ishii; Koichi Azuma; Akihiko Kawahara; Norikazu Matsuo; Takaaki Tokito; Tomoaki Hoshino
Investigational new drugs, Feb. 2021 - Phase I study of afatinib plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer harboring EGFR mutations.
Ryo Ko; Takehito Shukuya; Chiyo K Imamura; Takaaki Tokito; Naoko Shimada; Ryo Koyama; Kazuhiko Yamada; Hidenobu Ishii; Koichi Azuma; Kazuhisa Takahashi
Translational lung cancer research, Jan. 2021 - Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial.
Shingo Miyamoto; Koichi Azuma; Hidenobu Ishii; Akihiro Bessho; Shinobu Hosokawa; Nobuaki Fukamatsu; Hideo Kunitoh; Mari Ishii; Hiroshi Tanaka; Hiromi Aono; Yoshiro Nakahara; Kei Kusaka; Yukio Hosomi; Norihiro Kikuchi; Yoshiaki Mori; Hidetoshi Itani; Akinobu Hamada; Kazuhiko Yamada; Hiroaki Okamoto
JAMA oncology, 01 Jul. 2020 - Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC.
Hidenobu Ishii; Koichi Azuma; Akihiko Kawahara; Takashi Kinoshita; Norikazu Matsuo; Yoshiko Naito; Takaaki Tokito; Kazuhiko Yamada; Jun Akiba; Tomoaki Hoshino
Thoracic cancer, Apr. 2020 - Determination of Somatic Mutations and Tumor Mutation Burden in Plasma by CAPP-Seq during Afatinib Treatment in NSCLC Patients Resistance to Osimertinib.
Hidenobu Ishii; Koichi Azuma; Kazuko Sakai; Yoshiko Naito; Norikazu Matsuo; Takaaki Tokito; Kazuhiko Yamada; Tomoaki Hoshino; Kazuto Nishio
Scientific reports, 20 Jan. 2020 - Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.
Takayuki Takahama; Koichi Azuma; Mototsugu Shimokawa; Masayuki Takeda; Hidenobu Ishii; Terufumi Kato; Haruhiro Saito; Haruko Daga; Yuko Tsuboguchi; Isamu Okamoto; Kohei Otsubo; Hiroaki Akamatsu; Shunsuke Teraoka; Toshiaki Takahashi; Akira Ono; Tatsuo Ohira; Toshihide Yokoyama; Kazuko Sakai; Nobuyuki Yamamoto; Kazuto Nishio; Kazuhiko Nakagawa
Cancer, 01 Jan. 2020 - Tumor tissue and plasma levels of AXL and GAS6 before and after tyrosine kinase inhibitor treatment in EGFR-mutated non-small cell lung cancer.
Yoshikane Nonagase; Masayuki Takeda; Koichi Azuma; Hidetoshi Hayashi; Koji Haratani; Kaoru Tanaka; Kimio Yonesaka; Hidenobu Ishii; Tomoaki Hoshino; Kazuhiko Nakagawa
Thoracic cancer, Oct. 2019 - Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti-PD-1 inhibitor.
Norikazu Matsuo; Koichi Azuma; Satoshi Hattori; Junya Ohtake; Akihiko Kawahara; Hidenobu Ishii; Takaaki Tokito; Kazuhiko Yamada; Yuji Shibata; Tadasuke Shimokawaji; Tetsuro Kondo; Terufumi Kato; Haruhiro Saito; Kouzo Yamada; Tetsuro Sasada; Tomoaki Hoshino
International journal of cancer, 01 Mar. 2019 - Screening system for epidermal growth factor receptor mutation detection in cytology cell-free DNA of cerebrospinal fluid based on assured sample quality.
Akihiko Kawahara; Hideyuki Abe; Kazuya Murata; Hidenobu Ishii; Koichi Azuma; Yorihiko Takase; Satoshi Hattori; Yoshiki Naito; Jun Akiba
Cytopathology : official journal of the British Society for Clinical Cytology, Mar. 2019 - Prognostic Value of Serum Tumor Markers in Patients With Stage III NSCLC Treated With Chemoradiotherapy.
Takaaki Tokito; Koichi Azuma; Kazuhiko Yamada; Yoshiko Naito; Norikazu Matsuo; Hidenobu Ishii; Hiroki Natori; Takashi Kinoshita; Tomoaki Hoshino
In vivo (Athens, Greece), 2019 - Lung Cancer with a Small Cell Carcinoma Component Diagnosed from Pleural Effusion and a Squamous Cell Carcinoma Component Diagnosed from the Tumor.
Yoshiaki Zaizen; Takaaki Tokito; Ken Masuda; Koichi Azuma; Yoshiki Naito; Shingo Tsuneyoshi; Yuki Sakazaki; Norikazu Matsuo; Hidenobu Ishii; Kazuhiko Yamada; Jun Akiba; Tomoaki Hoshino
Internal medicine (Tokyo, Japan), 01 Dec. 2018 - Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
Fabrice Barlesi; Johan Vansteenkiste; David Spigel; Hidenobu Ishii; Marina Garassino; Filippo de Marinis; Mustafa Özgüroğlu; Aleksandra Szczesna; Andreas Polychronis; Ruchan Uslu; Maciej Krzakowski; Jong-Seok Lee; Luana Calabrò; Osvaldo Arén Frontera; Barbara Ellers-Lenz; Marcis Bajars; Mary Ruisi; Keunchil Park
The Lancet. Oncology, Nov. 2018 - The characteristics of nivolumab-induced colitis: an evaluation of three cases and a literature review.
Ryosuke Yamauchi; Toshihiro Araki; Keiichi Mitsuyama; Takaaki Tokito; Hidenobu Ishii; Shinichiro Yoshioka; Kotaro Kuwaki; Atsushi Mori; Tetsuhiro Yoshimura; Osamu Tsuruta; Takuji Torimura
BMC gastroenterology, 31 Aug. 2018 - Successful treatment with an EGFR tyrosine kinase inhibitor Afatinib in a patient with combined small-cell lung Cancer with EGFR mutation.
Midori Tanaka; Hidenobu Ishii; Hayato Moribuchi; Yoshiko Naito; Norikazu Matsuo; Masayuki Nakamura; Takaaki Tokito; Koichi Azuma; Kazuhiko Yamada; Tomoaki Hoshino
Investigational new drugs, Aug. 2018 - Pulmonary pleomorphic carcinoma: A case harboring EGFR mutation treated with EGFR-TKIs.
Ken Masuda; Takaaki Tokito; Koichi Azuma; Eriko Yanagida; Masayuki Nakamura; Yoshiko Naito; Norikazu Matsuo; Hidenobu Ishii; Kazuhiko Yamada; Jun Akiba; Tomoaki Hoshino
Thoracic cancer, Jun. 2018 - Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients.
Hiroaki Takeoka; Kazuhiko Yamada; Yoshiko Naito; Norikazu Matsuo; Hidenobu Ishii; Takaaki Tokito; Koichi Azuma; Masao Ichiki; Tomoaki Hoshino
Anticancer research, Jun. 2018 - Rechallenge treatment with a platinum-based regimen in patients with sensitive relapsed small-cell lung cancer.
Yoshiko Naito; Kazuhiko Yamada; Yohei Imamura; Hidenobu Ishii; Norikazu Matsuo; Takaaki Tokito; Takashi Kinoshita; Koichi Azuma; Tomoaki Hoshino
Medical oncology (Northwood, London, England), 02 Apr. 2018 - Aplastic anemia in a lung adenocarcinoma patient receiving pemetrexed.
Goushi Matama; Takaaki Tokito; Hiroaki Takeoka; Yuki Hiraoka; Norikazu Matsuo; Masayuki Nakamura; Hidenobu Ishii; Takashi Kinoshita; Koichi Azuma; Kazuhiko Yamada; Tomoaki Hoshino
Investigational new drugs, Oct. 2017 - Programmed cell death-ligand 1 expression and immunoscore in stage II and III non-small cell lung cancer patients receiving adjuvant chemotherapy.
Hidenobu Ishii; Koichi Azuma; Akihiko Kawahara; Norikazu Matsuo; Takaaki Tokito; Takashi Kinoshita; Kazuhiko Yamada; Tetsuro Sasada; Jun Akiba; Tomoaki Hoshino
Oncotarget, 22 Sep. 2017 - Accuracy of transbronchial biopsy as a rebiopsy method for patients with relapse of advanced non-small-cell lung cancer after systemic chemotherapy.
Hidenobu Ishii; Koichi Azuma; Kazuhiko Yamada; Norikazu Matsuo; Masayuki Nakamura; Takaaki Tokito; Takashi Kinoshita; Tomoaki Hoshino
BMJ open respiratory research, 2017 - Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients.
Norikazu Matsuo; Koichi Azuma; Kazuko Sakai; Satoshi Hattori; Akihiko Kawahara; Hidenobu Ishii; Takaaki Tokito; Takashi Kinoshita; Kazuhiko Yamada; Kazuto Nishio; Tomoaki Hoshino
Scientific reports, 04 Nov. 2016 - A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer.
Kazuhiko Yamada; Masao Ichiki; Kazuhisa Takahashi; Yasushi Hisamatsu; Hiroaki Takeoka; Koichi Azuma; Takehito Shukuya; Kazuo Nishikawa; Takaaki Tokito; Hidenobu Ishii; Tomoaki Hoshino
Cancer chemotherapy and pharmacology, Sep. 2016 - Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Takaaki Tokito; Koichi Azuma; Akihiko Kawahara; Hidenobu Ishii; Kazuhiko Yamada; Norikazu Matsuo; Takashi Kinoshita; Naohisa Mizukami; Hirofumi Ono; Masayoshi Kage; Tomoaki Hoshino
European journal of cancer (Oxford, England : 1990), Mar. 2016 - Sarcomatoid Type Primary Pericardial Mesothelioma with a Long-term Survival after the Onset of Cardiac Tamponade.
Chika Saisho; Hidenobu Ishii; Nobutaka Edakuni; Yohei Imamura; Takaaki Tokito; Takashi Kinoshita; Koichi Azuma; Kazuhiko Yamada; Tomoaki Hoshino
Internal medicine (Tokyo, Japan), 2016 - Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
Hidenobu Ishii; Koichi Azuma; Kazuko Sakai; Akihiko Kawahara; Kazuhiko Yamada; Takaaki Tokito; Isamu Okamoto; Kazuto Nishio; Tomoaki Hoshino
Oncotarget, 13 Oct. 2015 - Epidermal growth factor receptor mutation status in cell-free DNA supernatant of bronchial washings and brushings.
Akihiko Kawahara; Chihiro Fukumitsu; Tomoki Taira; Hideyuki Abe; Yorihiko Takase; Kazuya Murata; Tomohiko Yamaguchi; Koichi Azuma; Hidenobu Ishii; Shinzo Takamori; Jun Akiba; Tomoaki Hoshino; Masayoshi Kage
Cancer cytopathology, Oct. 2015 - Ulcerative colitis in a patient with non-small-cell lung cancer receiving bevacizumab.
Midori Tanaka; Hidenobu Ishii; Koichi Azuma; Chika Saisho; Norikazu Matsuo; Yohei Imamura; Takaaki Tokito; Takashi Kinoshita; Kazuhiko Yamada; Hidetoshi Takedatsu; Keiichi Mitsuyama; Tomoaki Hoshino
Investigational new drugs, Oct. 2015 - Heterogeneity of anaplastic lymphoma kinase gene rearrangement in non-small-cell lung carcinomas: a comparative study between small biopsy and excision samples.
Hideyuki Abe; Akihiko Kawahara; Koichi Azuma; Tomoki Taira; Yorihiko Takase; Chihiro Fukumitsu; Kazuya Murata; Tomohiko Yamaguchi; Jun Akiba; Hidenobu Ishii; Isamu Okamoto; Tomoaki Hoshino; Shinzou Takamori; Masayoshi Kage
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, May 2015 - Paired maximum inspiratory and expiratory plain chest radiographs for assessment of airflow limitation in chronic obstructive pulmonary disease.
Takashi Kinoshita; Tomotaka Kawayama; Youhei Imamura; Yuki Sakazaki; Ryo Hirai; Hidenobu Ishii; Masashi Suetomo; Kazuko Matsunaga; Koichi Azuma; Kiminori Fujimoto; Tomoaki Hoshino
European journal of radiology, Apr. 2015 - Significance of programmed cell death-ligand 1 expression and its association with survival in patients with small cell lung cancer.
Hidenobu Ishii; Koichi Azuma; Akihiko Kawahara; Kazuhiko Yamada; Yohei Imamura; Takaaki Tokito; Takashi Kinoshita; Masayoshi Kage; Tomoaki Hoshino
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Mar. 2015 - Predictive factors in patients with EGFR mutation-negative non-small cell lung cancer treated with erlotinib.
Hidenobu Ishii; Koichi Azuma; Kazuhiko Yamada; Takashi Kinoshita; Youhei Imamura; Tomoaki Hoshino
Oncology letters, Dec. 2014 - Metachronous bilateral pulmonary metastases from cancer of the ampulla duodeni.
Motohisa Kuwahara; Hidenobu Ishii; Kazuya Naritomi; Masae Mano; Jun Yanagisawa; Takayuki Shirakusa; Akinori Iwasaki
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2014
- 【COVID-19との闘い】久留米大学医学部内科学講座呼吸器・神経・膠原病内科部門における新型コロナウイルス感染症の世界的流行の初期における対応の記録
石井 秀宣; 星野 友昭
久留米医学会雑誌, Dec. 2023 - Noninvasive detection of acquired T790M mutation in NSCLC patients treated with EGFR-TKI using digital PCR of plasma
Hidenobu Ishii; Koichi Azuma; Kazuko Sakai; Takaaki Tokito; Kazuhiko Yamada; Kazuto Nishio; Tomoaki Hoshibo
ANNALS OF ONCOLOGY, Nov. 2015 - Digital PCR Analysis of Plasma Cell-Free DNA as a Noninvasive Detection of the Drug Resistance Mechanisms in EGFR Mutant NSCLC
Hidenobu Ishii; Koichi Azuma; Kazuko Sakai; Takaaki Tokito; Kazuhiko Yamada; Kazuto Nishio; Tomoaki Hoshino
JOURNAL OF THORACIC ONCOLOGY, Sep. 2015
- Association of T-lymphokine-activated killer cell-originated protein kinase expression with epidermal growth factor receptor mutations in surgically resected non-small-cell lung cancer
Grant-in-Aid for Young Scientists (B)
Kurume University
01 Apr. 2015 - 31 Mar. 2017
